Shares of Baxter International have underperformed the rest of the healthcare sector, but the medical device maker is the perfect contrarian play due to its repeatable revenue model and impressive dividend, says Burns McKinney, portfolio manager for the AllianzGI NFJ Dividend Value fund. McKinney also says Norfolk Southern is trading cheaply versus its peers and offers a reliable, growing dividend. Finally, McKinney says MetLife will be a strong performer as it expands internationally.
More from Video
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Breaking down an approach to the long side of this biotech stock.
AMSC CEO discusses that and China challenges.
One of pharma's biggest CEO's talks M&A action on the exchange.